Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 2, 2010, Pages 566-573

  Hoseok, I ^a   Ko, Eunkyung ^b   Kim, Yujin ^b   Cho, Eun Yoon ^b   Han, Joungho ^b   Park, Joobae ^b,c   Kim, Kwhanmien ^b   Kim, Duk Hwan ^b,c   Shim, Young Mog ^b  

^a Pusan National University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HISTONE; HISTONE H3; HISTONE H4; LYSINE;

ACETYLATION; ADULT; AGED; ALGORITHM; ARTICLE; CANCER STAGING; CLUSTER ANALYSIS; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN MODIFICATION; RECURRENCE FREE SURVIVAL;

ACETYLATION; ADULT; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HISTONES; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TISSUE ARRAY ANALYSIS;

EID: 76149132313     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0980     Document Type: Article

References (24)

1. Enzinger WJ, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349: 2241-52.
2. Osugi H, Takemura M, Higashino M, et al. Causes of death and pattern of recurrence after esophagectomy and extended lymphadectomy for squamous cell carcinoma of the thoracic esophague. Oncol Rep 2003;10:81-7.
3. Yasui W, Oue N, Ono S, Mitani Y, Ito R, Nakayama H. Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci 2003;983:220-31.
4. Fraga MF, Ballestar E, Villar-Garea A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005;37:391-400.
5. Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005;435: 1262-6.
6. Seligson DB, Horvath S, McBrian MA, et al. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 2009;174:1619-28.
7. Barlési F, Giaccone G, Gallegos-Ruiz MI, et al. Global histone modifications predict prognosis of resected non small-cell lung cancer. J Clin Oncol 2007;25:4358-64.
8. Van Den Broeck A, Brambilla E, Moro-Sibilot D, et al. Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer. Clin Cancer Res 2008; 14:7237-45.
9. Wei Y, Xia W, Zhang Z, et al. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 2008;479:701-6.
10. Elsheikh SE, Green AR, Rakha EA, et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 2009;69:3802-9.
11. Park YS, Jin MY, Kim YJ, Yook JH, Kim BS, Jang SJ. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 2008; 15:1968-76.
12. Toh Y, Yamamoto M, Endo K, et al. Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep 2003;10:333-8.
13. Tzao C, Sun GH, Tung HJ, et al. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma. Ann Thorac Surg 2006;82:396-401.
14. Tzao C, Tung HJ, Jin JS, et al. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus. Mod Pathol 2009;22:252-60.
15. Johnson L, Cao X, Jacobsen S. Interplay between two epigenetic marks. DNA methylation and histone H3 lysine 9 methylation. Curr Biol 2002;12:1360-7.
16. Snowden AW, Gregory PD, Case CC, Pabo CO. Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr Biol 2002;12:2159-66.
17. Greene F, Page D, Fleming I, et al. Esophagus. AJCC cancer staging manual. pp. 91-5New York: Springer-Verlag; 2002.
18. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001; 159:2249-56.
19. Kurdistani SK, Tavazoie S, Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 2004;117:721-33.
20. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403:41-5.
21. Wang Z, Zang C, Rosenfeld JA, et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008;40:897-903.
22. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK. Epigenetic reprogramming by adenovirus e1a. Science 2008;321: 1086-8.
23. Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ. Adenovirus small e1a alters global patterns of histone modification. Science 2008;321:1084-5.
24. Zhao Q, Rank G, Tan YT, et al. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing. Nat Struct Mol Biol 2009;16:304-11.